Naz News, Gappers and FLE's

[MWM]

ROKA grabbed a bunch at $2.05 on this news!

Roka Bioscience (ROKA) surged 153% to their highest level in more than two months -- piercing their 50- and 100-day moving averages for the first time since April -- in the wake of a disclosure Edward Painter, CEO of A2A Pharmaceuticals, has acquired 340,000 shares of Roka, or 6.79%. "Edward Painter purchased shares with the intention of seeking a business combination with A2A Pharmaceuticals, a private biotechnology company," according to a regulatory statement. "He may sell shares or buy additional shares or change his purpose of transacting in the future." Roka sold substantially all of its assets in August to a subsidiary of Institute for Environmental Health for $17.5 million in cash, the initial step in a contemplated liquidation of the molecular diagnostics company.